740831
Last Update Posted: 2012-12-17
Recruiting has ended
Females accepted | 18 Years-50 Years |
301 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
PGL4001 Versus GnRH-agonist in Uterine Myomas
This trial will assess the efficacy and safety of PGL4001 versus GnRH agonist, over a 3-month period for the pre-operative treatment of pre-menopausal women suffering from excessive uterine bleeding due to uterine myoma.
Eligibility
Relevant conditions:
Uterine Myomas
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov